Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-07-28 Sale |
2025-07-30 4:30 pm |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
937 | $6.98 | $6,540 | 81,870 (Direct) |
View |
| 2025-06-30 Sale |
2025-07-02 4:30 pm |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
781 | $5.04 | $3,936 | 82,807 (Direct) |
View |
| 2025-03-18 Sale |
2025-03-20 4:36 pm |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
45,316 | $8.7606 | $396,995 | 279,004 (Direct) |
View |
| 2025-03-18 Sale |
2025-03-20 4:36 pm |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
32,146 | $8.7623 | $281,673 | 127,349 (Direct) |
View |
| 2025-03-18 Sale |
2025-03-20 4:35 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
26,172 | $8.7737 | $229,624 | 225,740 (Direct) |
View |
| 2025-03-17 Sale(A) |
2025-03-20 4:35 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
31,278 | $8.8224 | $275,947 | 155,512 (Direct) |
View |
| 2025-03-17 Sale |
2025-03-19 4:12 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
31,278 | $8.8224 | $275,947 | 155,512 (Direct) |
View |
| 2025-03-17 Sale |
2025-03-19 4:06 pm |
Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks |
5,000 | $8.8338 | $44,169 | 38,038 (Direct) |
View |
| 2025-01-15 Sale |
2025-01-17 4:30 pm |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
13,534 | $7.225 | $97,783 | 110,673 (Direct) |
View |
| 2025-01-15 Sale |
2025-01-17 4:30 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
14,322 | $7.225 | $103,476 | 96,790 (Direct) |
View |
| 2025-01-15 Sale |
2025-01-17 4:30 pm |
Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks |
9,511 | $7.225 | $68,717 | 43,038 (Direct) |
View |
| 2025-01-15 Sale |
2025-01-17 4:30 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
21,704 | $7.225 | $156,811 | 251,912 (Direct) |
View |
| 2025-01-15 Sale |
2025-01-17 4:30 pm |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
10,428 | $7.225 | $75,342 | 79,320 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-07-28 Exercise |
2025-07-30 4:30 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
937 | $0 | 81,870 (Direct) |
View |
| 2025-07-28 Exercise |
2025-07-30 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
937 | $1.29 | 81,870 (Direct) |
View |
| 2025-06-30 Exercise |
2025-07-02 4:30 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
781 | $0 | 82,807 (Direct) |
View |
| 2025-06-30 Exercise |
2025-07-02 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
781 | $1.29 | 82,807 (Direct) |
View |
| 2025-06-25 Option Award |
2025-06-26 08:30 am |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
5,353 | $4.67 | 90,865 (Direct) |
View |
| 2025-06-25 Option Award |
2025-06-26 08:30 am |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
42,826 | $4.67 | 268,566 (Direct) |
View |
| 2025-06-25 Option Award |
2025-06-26 08:30 am |
N/A N/A |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
1,070,663 | $4.67 | 5,197,821 (Indirect) |
View |
| 2025-06-25 Option Award |
2025-06-26 08:30 am |
N/A N/A |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
111,349 | $4.67 | 546,863 (Indirect) |
View |
| 2025-06-25 Option Award |
2025-06-26 08:30 am |
N/A N/A |
Candel Therapeutics Inc. | CADL | Loggia Nicoletta Director |
2,141 | $4.67 | 2,141 (Direct) |
View |
| 2025-06-25 Option Award |
2025-06-26 08:30 am |
N/A N/A |
Candel Therapeutics Inc. | CADL | Schoch Charles Chief Financial Officer |
5,353 | $4.67 | 43,391 (Direct) |
View |
| 2025-06-25 Option Award |
2025-06-26 08:30 am |
N/A N/A |
Candel Therapeutics Inc. | CADL | Nabel Gary J. Director |
5,353 | $4.67 | 5,353 (Direct) |
View |
| 2025-06-25 Option Award |
2025-06-26 08:30 am |
N/A N/A |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
4,282 | $4.67 | 100,809 (Direct) |
View |
| 2025-06-25 Option Award |
2025-06-26 08:30 am |
N/A N/A |
Candel Therapeutics Inc. | CADL | PAPA JOSEPH C Director |
64,239 | $4.67 | 102,271 (Indirect) |
View |
| 2025-06-20 Option Award |
2025-06-24 4:30 pm |
N/A 2035-06-20 |
Candel Therapeutics Inc. | CADL | Schoch Charles Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2025-06-17 Option Award |
2025-06-18 08:38 am |
N/A 2035-06-17 |
Candel Therapeutics Inc. | CADL | Benz Edward J. JR Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2025-06-17 Option Award |
2025-06-18 08:37 am |
N/A 2035-06-17 |
Candel Therapeutics Inc. | CADL | Gaeta Renee Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2025-06-17 Option Award |
2025-06-18 08:36 am |
N/A 2035-06-17 |
Candel Therapeutics Inc. | CADL | Loggia Nicoletta Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2025-06-17 Option Award |
2025-06-18 08:35 am |
N/A 2035-06-17 |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2025-06-17 Option Award |
2025-06-18 08:34 am |
N/A 2035-06-17 |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2025-06-17 Option Award |
2025-06-18 08:33 am |
N/A 2035-06-17 |
Candel Therapeutics Inc. | CADL | Nabel Gary J. Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2025-06-17 Option Award |
2025-06-18 08:33 am |
N/A 2035-06-17 |
Candel Therapeutics Inc. | CADL | Nguyen Diem Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2025-06-17 Option Award |
2025-06-18 08:32 am |
N/A 2035-06-17 |
Candel Therapeutics Inc. | CADL | PAPA JOSEPH C Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2025-06-04 Option Award |
2025-06-06 4:36 pm |
N/A 2035-06-04 |
Candel Therapeutics Inc. | CADL | Radhakrishnan Maha Director |
28,480 | $0 | 28,480 (Direct) |
View |
| 2025-03-18 Exercise |
2025-03-20 4:36 pm |
N/A 2032-09-12 |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
18,489 | $0 | 279,004 (Direct) |
View |
| 2025-03-18 Exercise |
2025-03-20 4:36 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
13,905 | $1.29 | 279,004 (Direct) |
View |
| 2025-03-18 Exercise |
2025-03-20 4:36 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
4,584 | $3.75 | 279,004 (Direct) |
View |
| 2025-03-18 Exercise |
2025-03-20 4:36 pm |
N/A 2030-12-30 |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
18,000 | $0 | 127,349 (Direct) |
View |
| 2025-03-18 Exercise |
2025-03-20 4:36 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
18,000 | $1.55 | 127,349 (Direct) |
View |
| 2025-03-17 Exercise(A) |
2025-03-20 4:35 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
20,000 | $0 | 155,512 (Direct) |
View |
| 2025-03-17 Exercise(A) |
2025-03-20 4:35 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
20,000 | $1.29 | 155,512 (Direct) |
View |
| 2025-03-17 Exercise |
2025-03-19 4:12 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
20,000 | $0 | 155,512 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:30 pm |
N/A 2035-02-12 |
Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks |
83,000 | $0 | 83,000 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:30 pm |
N/A 2035-02-12 |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
107,250 | $0 | 107,250 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:30 pm |
N/A 2035-02-12 |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
65,000 | $0 | 65,000 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:30 pm |
N/A 2035-02-12 |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
525,000 | $0 | 525,000 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:30 pm |
N/A 2035-02-12 |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
115,000 | $0 | 115,000 (Direct) |
View |